A 29-year-old man presenting with a retroperitoneal mass was found to have a testis lesion consistent with mixed germ cell tumor and the RPLND specimen showed teratoma with an area of central nervous system-type primitive neuroectodermal tumor (PNET) not present in the testis. Whether such primitive tumor components represent a de novo tumor component or represent progression from existing neuroepithelial teratomatous elements is unclear. Given the high likelihood of residual tumor and possibility of malignant transformation, post-chemotherapy RPLND remains vital in treating patients with testis cancer. PNET is chemo-resistant and lesions should be resected, without clear evidence for adjuvant chemotherapy. 
a b s t r a c t
A 29-year-old man presenting with a retroperitoneal mass was found to have a testis lesion consistent with mixed germ cell tumor and the RPLND specimen showed teratoma with an area of central nervous system-type primitive neuroectodermal tumor (PNET) not present in the testis. Whether such primitive tumor components represent a de novo tumor component or represent progression from existing neuroepithelial teratomatous elements is unclear. Given the high likelihood of residual tumor and possibility of malignant transformation, post-chemotherapy RPLND remains vital in treating patients with testis cancer. PNET is chemo-resistant and lesions should be resected, without clear evidence for adjuvant chemotherapy. 
Case presentation
A previously healthy 29-year-old man presented with intermittent right lower quadrant and flank pain. On computed tomography (CT) he was found to have a right-sided retroperitoneal mass measuring 13 Â 11 Â 7 cm, encasing the aorta, compressing the inferior vena cava and right ureter, and causing moderate hydronephrosis (Fig. 1) . Testis tumor markers were significant for afetoprotein (AFP) of 1960 ug/l, lactate dehydrogenase (LDH) of 863 U/l, and b-human chorionic gonadotropin (HCG) of less than 0.5 IU/l. Scrotal ultrasound revealed two small discrete adjacent right intratesticular lesions, 12 Â 9 Â 11 mm and 9 Â 6 Â 6 mm with a normal contralateral testis. Pathologic examination of the orchiectomy revealed a 2 cm mixed germ cell tumor (50% seminoma, classic type and 50% teratoma without immature elements) that was partially necrotic and surrounded by organizing granulation tissue and scar. The tumor did not extend beyond the testicular parenchyma and did not involve lymphovascular spaces or the cord margin. Post-operative markers remained elevated (AFP 2433, LDH 656, hCG <0.5). As IGCCCG intermediate-risk (T1N3M0S2) he underwent 3 cycles of bleomycin, etoposide, and cisplatin and after developing a dry cough, his fourth cycle was limited to etoposide and cisplatin. His tumor markers normalized and he underwent a retroperitoneal lymph node dissection (RPLND). Pathology revealed an 8 cm metastasis composed of teratoma and seminoma plus a 
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Urology Case Reports j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / e u c r 2 cm focus of poorly-differentiated high grade small round blue cells resembling malignant primitive neural elements. The primitive tumor cells showed immunohistochemical expression of synaptophysin but not of CD99 (Fig. 2) . Embryonal carcinoma and rhabdomyosarcoma were excluded by immunohistochemistry (negative SALL4, OCT4, desmin and myogenin). The morphology and immunophenotype of the cells in question was classified as a form of central nervous system-type primitive neuroectodermal tumor (CNS-type PNET). Re-examination of the slides of the primary testicular tumor did not reveal any similar tumor component but it was not possible to determine the tumor type that originally occupied the areas of necrosis and scar adjacent to viable seminoma and teratoma.
Discussion
Teratomas represent approximately 4% of testicular germ cell tumors, but display complex histology and a heterogeneous clinical progression. 1 Although some may be inert or only locally aggressive, 3e8% of testicular teratomas have the potential for transformation of the epithelial elements to carcinoma or mesenchymal elements to sarcoma. Rarely, primary or metastatic testicular germ cell tumors may contain tumor components that morphologically resemble central nervous system medulloblastoma or medulloepithelioma (so-called CNS-type PNET) or Ewing sarcoma (previously referred to as peripheral-type PNET 
Conclusion
Given the high likelihood of residual tumor and possibility of malignant transformation of teratoma into aggressive histology, post-chemotherapy RPLND remains vital in treating patients with testis cancer. In addition, PNET is chemo-resistant and recurrent lesions should be resected, without clear evidence for adjuvant chemotherapy in this setting.
